Voluntary medical male circumcision (VMMC) is reported as the number of males circumcised with support from PEPFAR funds. This number is broken down by age, HIV status, and circumcision technique. An additional breakdown of surgical circumcisions by follow-up status within 14 days is included to monitor program quality. The number of circumcisions performed indicates the reach of services and whether targets are met, while disaggregations allow evaluation of which populations are accessing services and adjustment of modeling inputs.
Addressing Medical Necessity Denials and RecoupmentsPYA, P.C.
With increased denials and recoupments related to medical necessity at the forefront of discussions at this year’s American Health Lawyers Association Institute on Medicare and Medicaid Payment Issues, PYA was prepared to inform and assist providers instituting best practices to address medical necessity denials. PYA Principal Denise Hall-Gaulin co-presented “Medical Status-Current Status/Key Best Practices in Prevention of Medical Necessity Denials and Recoupments” with Michael Spake, VP of External Affairs and Chief Compliance and Integrity Officer at Lakeland Regional Health.
The presentation included:
A discussion of medical necessity—what it means and what it affects
Information regarding medical necessity determinations and criteria for determination
Definitions for categorically excluded services
Criteria for admission (skilled nursing facilities and inpatient rehabilitation facilities included)
Understanding the Satisfaction, Perceptions, and Expectations of Clients of P...HFG Project
Taking quality health care to the farthest corners of the country is at the heart of the Government of India’s public health policy and programming. The National Health Mission’s reproductive, maternal, newborn, child and adolescent health (RMNCH+A) strategic approach underscores the need to ensure quality health care. A key thrust of the government’s reform focus has, thus, been on plugging service delivery gaps through improved, evidence-based decision making. The USAID-funded Health Finance and Governance (HFG) project supported the country’s Ministry of Health and Family Welfare (MoHFW) to yield preliminary insights into the level of patient satisfaction and utilization of public health services.
Did you know that ALL of your Medicare reimbursements will be docked if you don't participate in the PQRS reporting program? This applies to mental / behavioral heath and substance abuse providers - get the full scoop in our guide.
Addressing Medical Necessity Denials and RecoupmentsPYA, P.C.
With increased denials and recoupments related to medical necessity at the forefront of discussions at this year’s American Health Lawyers Association Institute on Medicare and Medicaid Payment Issues, PYA was prepared to inform and assist providers instituting best practices to address medical necessity denials. PYA Principal Denise Hall-Gaulin co-presented “Medical Status-Current Status/Key Best Practices in Prevention of Medical Necessity Denials and Recoupments” with Michael Spake, VP of External Affairs and Chief Compliance and Integrity Officer at Lakeland Regional Health.
The presentation included:
A discussion of medical necessity—what it means and what it affects
Information regarding medical necessity determinations and criteria for determination
Definitions for categorically excluded services
Criteria for admission (skilled nursing facilities and inpatient rehabilitation facilities included)
Understanding the Satisfaction, Perceptions, and Expectations of Clients of P...HFG Project
Taking quality health care to the farthest corners of the country is at the heart of the Government of India’s public health policy and programming. The National Health Mission’s reproductive, maternal, newborn, child and adolescent health (RMNCH+A) strategic approach underscores the need to ensure quality health care. A key thrust of the government’s reform focus has, thus, been on plugging service delivery gaps through improved, evidence-based decision making. The USAID-funded Health Finance and Governance (HFG) project supported the country’s Ministry of Health and Family Welfare (MoHFW) to yield preliminary insights into the level of patient satisfaction and utilization of public health services.
Did you know that ALL of your Medicare reimbursements will be docked if you don't participate in the PQRS reporting program? This applies to mental / behavioral heath and substance abuse providers - get the full scoop in our guide.
Office of Civil Rights HIPAA Audits Preparing Your Clients and YourselfPYA, P.C.
PYA Consulting Manager Susan Thomas presented “Office of Civil Rights HIPAA Audits – Preparing Your Clients and Yourself” at The Florida Bar’s “Representing the Physician: It Is Harder Than It Looks” conference, February 3, 2017, in Orlando, Florida.
The presentation covered topics that include:
The Health Information Technology for Economic and Clinical Health Act.
Phase 1 audit, privacy, security, and breach notification findings and lessons learned.
Phase 2 audits—scope and recipient selection.
HIPAA audit readiness and steps for preparing.
Personal reflections from an OCR breach investigation.
Audit resources for physician practices.
Current Trends in Data Protection for Integrated Health, Centralized Peer Rev...PYA, P.C.
A webinar hosted by PYA and the Alliance for Quality Improvement (AQIPS) explored “Current Trends in Data Protection for Integrated Health, Centralized Peer Review Systems, and Other Innovative Programs.” PYA Principal Martie Ross participated in the webinar, which focused on how patient safety organization (PSO) protections can bring value to accountable care organizations and other integrated health systems.
In addition, the webinar provided instruction for using:
Patient Safety and Quality Improvement Act (PSQIA) protections in Medicare Shared Savings Programs, centralized peer review programs, and other collaboratives.
PSQIA protections for new types of clinical analysis, clinical quality reports, and performance tools that contain information that may not be protected under existing state peer review privilege or are shared among an integrated network.
Patient Registries: A New Pillar of Modern CareQ-Centrix
www.q-centrix.com
A vital resource for patient data are registries. This white paper examines the rise of patient registries, how hospitals are taking advantage of the data, the challenges hospitals face in submitting quality information, and the benefits of real-time registry reporting.
White Paper - Infection Preventionists: Healthcare’s Guardians at the Gate Ne...Q-Centrix
This white paper examines a key player at the front lines of hospitals’ never-ending battles against HAIs –Infection Preventionists (IPs). It briefly explains their varied roles, responsibilities and new challenges, the difficulty in recruiting these highly sought-after experts, and why and how hospitals should be doing more to help overworked and understaffed IPs be successful. Lastly, it covers new technologies and IP support services that can be integrated into hospitals’ infection control practices.
This is a primer, aimed at health care administrators and practitioners, for introducing an SBIRT -- Screening, Brief Intervention, and Referral for Treatment -- program in any health care facility.
Zimbabwe: Results-Based Financing Improves Coverage, Quality and Financial Pr...RBFHealth
A presentation by Dr. Gwinji, Permanent Secretary, Ministry of Health, Zimbabwe and Dr. Tafadzwa Goverwa- Sibanda, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
Engaging Non-State Actors in Governing Health: Key to Improving Quality of Care?HFG Project
USAID’s Health Finance and Governance (HFG) and the Joint Learning Network hosted an hour-long webinar on engaging non-state actors in governing quality of care. The webinar presented in-country examples of private sector contributions in governing health quality — providing technical inputs on policy development, monitoring health service delivery, and promoting accountability in the health system.
Measuring & Monitoring Clinical Quality Measures Using Practice FusionPractice Fusion
Review CMS quality measures, how to capture the data in Practice Fusion, and how this data can be used to earn incentive payments through quality reporting programs, including Meaningful Use and PQRS.
PYA Principal J. Michael Keegan, MD, recently presented “Pacing Volume-to-Value Transition” and “The ROI of Avoiding Antibiotic Overuse” at the AlaHA Annual Meeting, June 8-11, 2016. The presentation focused on the importance of antibiotic stewardship programs (ASP) for population health. The presentation explained:
Why the Centers for Medicare & Medicaid Services is proposing a requirement that hospitals implement ASPs to stem the rise of resistant bacteria.
Why PYA is invested in offering hospitals a proven program for improving patient safety while saving costs.
What constitutes a successful ASP.
Office of Civil Rights HIPAA Audits Preparing Your Clients and YourselfPYA, P.C.
PYA Consulting Manager Susan Thomas presented “Office of Civil Rights HIPAA Audits – Preparing Your Clients and Yourself” at The Florida Bar’s “Representing the Physician: It Is Harder Than It Looks” conference, February 3, 2017, in Orlando, Florida.
The presentation covered topics that include:
The Health Information Technology for Economic and Clinical Health Act.
Phase 1 audit, privacy, security, and breach notification findings and lessons learned.
Phase 2 audits—scope and recipient selection.
HIPAA audit readiness and steps for preparing.
Personal reflections from an OCR breach investigation.
Audit resources for physician practices.
Current Trends in Data Protection for Integrated Health, Centralized Peer Rev...PYA, P.C.
A webinar hosted by PYA and the Alliance for Quality Improvement (AQIPS) explored “Current Trends in Data Protection for Integrated Health, Centralized Peer Review Systems, and Other Innovative Programs.” PYA Principal Martie Ross participated in the webinar, which focused on how patient safety organization (PSO) protections can bring value to accountable care organizations and other integrated health systems.
In addition, the webinar provided instruction for using:
Patient Safety and Quality Improvement Act (PSQIA) protections in Medicare Shared Savings Programs, centralized peer review programs, and other collaboratives.
PSQIA protections for new types of clinical analysis, clinical quality reports, and performance tools that contain information that may not be protected under existing state peer review privilege or are shared among an integrated network.
Patient Registries: A New Pillar of Modern CareQ-Centrix
www.q-centrix.com
A vital resource for patient data are registries. This white paper examines the rise of patient registries, how hospitals are taking advantage of the data, the challenges hospitals face in submitting quality information, and the benefits of real-time registry reporting.
White Paper - Infection Preventionists: Healthcare’s Guardians at the Gate Ne...Q-Centrix
This white paper examines a key player at the front lines of hospitals’ never-ending battles against HAIs –Infection Preventionists (IPs). It briefly explains their varied roles, responsibilities and new challenges, the difficulty in recruiting these highly sought-after experts, and why and how hospitals should be doing more to help overworked and understaffed IPs be successful. Lastly, it covers new technologies and IP support services that can be integrated into hospitals’ infection control practices.
This is a primer, aimed at health care administrators and practitioners, for introducing an SBIRT -- Screening, Brief Intervention, and Referral for Treatment -- program in any health care facility.
Zimbabwe: Results-Based Financing Improves Coverage, Quality and Financial Pr...RBFHealth
A presentation by Dr. Gwinji, Permanent Secretary, Ministry of Health, Zimbabwe and Dr. Tafadzwa Goverwa- Sibanda, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
Engaging Non-State Actors in Governing Health: Key to Improving Quality of Care?HFG Project
USAID’s Health Finance and Governance (HFG) and the Joint Learning Network hosted an hour-long webinar on engaging non-state actors in governing quality of care. The webinar presented in-country examples of private sector contributions in governing health quality — providing technical inputs on policy development, monitoring health service delivery, and promoting accountability in the health system.
Measuring & Monitoring Clinical Quality Measures Using Practice FusionPractice Fusion
Review CMS quality measures, how to capture the data in Practice Fusion, and how this data can be used to earn incentive payments through quality reporting programs, including Meaningful Use and PQRS.
PYA Principal J. Michael Keegan, MD, recently presented “Pacing Volume-to-Value Transition” and “The ROI of Avoiding Antibiotic Overuse” at the AlaHA Annual Meeting, June 8-11, 2016. The presentation focused on the importance of antibiotic stewardship programs (ASP) for population health. The presentation explained:
Why the Centers for Medicare & Medicaid Services is proposing a requirement that hospitals implement ASPs to stem the rise of resistant bacteria.
Why PYA is invested in offering hospitals a proven program for improving patient safety while saving costs.
What constitutes a successful ASP.
CMS Core Measures Compliance: Best Practices for Data Collection, Analysis and Reporting
For many hospitals, the primary challenge with the core measure program is not achieving quality standards, but complying with the complex, time-consuming reporting process and staying current with constantly changing regulations.
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...Cancer Institute NSW
The commonly understood model of shift to shift nursing handover does not apply to most ambulatory day treatment units. Nonetheless, ‘handover’ of patient clinical information remains quintessential to safe clinical practice. Of considerable interest is how EMR may aid the transfer of patient clinical information in these circumstances and address the question: does this facilitate improved patient care?
Lessening the Negative Impact of Human Factors Linking Staffing Variables & P...API Healthcare
In the United States, healthcare is a $2.9 trillion industry, costs $9,255 per capita and consumes 17.4% of the GDP.1 Healthcare is big business, and the way the entire industry conducts business is changing. While hospitals have always been in the business of providing patient care, the care delivery and payment models are undergoing an enormous paradigm shift. It’s no longer about the number of services provided, but instead about the quality of care delivered.
Insurance reimbursement in the oncology marketsmithjgrace
New payment models, especially for those providing oncology medical billing services, have been designed to improve the value and effectiveness of medical care. For this, the Centre of Medicare and Medicaid Innovation devised a new model called the 'Oncology Care Model.' "Under the Oncology Care Model (OCM), physician practices have entered into payment arrangements that include financial and performance accountability for episodes of care surrounding chemotherapy administration to cancer patients.
10 benefits of Remote Patient Monitoring (RPM).pdfHealthmote
Healthmote is one of the best remote patient monitoring services provider in USA. Remote patient monitoring uses equipment and technology in your home to send information about your health to clinicians on our team. Our remote patient monitoring program helps you stay informed about your condition while at home, and increases your independence in managing it. For more information visit us at healthmote.com today!
Hiv Prevention Nevada #ENDHIV #AIDSFREE#GOMOJO, INC.
Quality Management
The Nevada Ryan White Part B Program is committed to improving the quality of care and services for persons living with HIV and AIDS through continuous quality monitoring and improvement in a comprehensive performance measurement program.
NEVADA STATEWIDE HIV CONTINUUM OF CARE
The Nevada Statewide HIV Care Continuum and HIV Fast Facts shows all HIV/AIDS positive persons in the State of Nevada. This data includes persons who are engaged in care either in private clinics or a Ryan White Program, as well as, persons who are not engaged in care or not connected to a Ryan White Program.
Nevada Statewide HIV Continuum of Care 2017
Nevada Statewide HIV Continuum of Care 2016
2017 HIV Fast Facts
NEVADA RYAN WHITE PART B HIV CONTINUUM OF CARE
The Nevada Ryan White Part B Program HIV Care Cascade shows HIV/AIDS positive persons who have engaged in care and received at lease one service from the Nevada Ryan White Part B Program during the reported year.
HIV Care Cascade Calendar Year 2017
HIV Prevention Data Calendar Year 2017
NEVADA RYAN WHITE PART B QUALITY MANAGEMENT
The mission of the Nevada Ryan White Part B Program Quality Management Program is to improve access and ensure the highest quality medical care and supportive services through continuous evaluation, strategic planning and assessment, and the implementation of quality management and quality improvement projects.
Quality Management Plan 2018-2019
Quality Plan Performance Review 2018 Mid-Year Report
Calendar Year 2018 Reports
Viral Suppression by Disparities CY 2018- Age
Viral Suppression by Disparities CY 2018- Gender
Viral Suppression by Disparities CY 2018- HIV Risk Factor
Viral Suppression by Disparities CY 2018- Housing Status
Viral Suppression by Disparities CY 2018- Race and Ethnicity
Viral Suppression by Disparities CY 2018- All Disparity Data
Viral Suppression by Disparities CY 2018- ADAP Assistance
Grant Year 2018-2019 Mid-Year Reports
Viral Suppression by Disparities 2018 Mid-Year Report
Viral Suppression by Disparities 2018 Mid-Year Report-Age
Viral Suppression by Disparities 2018 Mid-Year Report-Gender
Viral Suppression by Disparities 2018 Mid-Year Report-HIV Risk Factor
Viral Suppression by Disparities 2018 Mid-Year Report-Housing
Viral Suppression by Disparities 2018 Mid-Year Report-Race and Ethnicity
Ryan White Part B Calendar Year 2017 Statistics
If you have any questions concerning Quality Management, please contact the person(s) below:
Samantha Penn, MBA
Management Analyst I
(Quality Assurance & Evaluation Analyst)
Phone: (702) 486-8103
Email: spenn@health.nv.gov
Core practices that are moving from a pilot state to implementation at scale: Many of the
barriers facing HIV programs are common across countries. PEPFAR’s ECTs (described below in
Sections 2.3.2 and 2.3.3) identified common issues affecting countries at various levels of
epidemic control and then developed a compendium of evidence-based solutions, approaches
and case-studies that highlight successful means of addressing common barriers. Additional
evidence-based approaches and case-studies will be incorporated into this living compendium
over time. As highlighted in this PEPFAR Solutions Platform, these practices can be rapidly
adapted and scaled to move countries forward.
Key considerations for all PEPFAR programs include:
• Bringing Interventions to Scale with Fidelity: Getting to HIV epidemic control is dependent on
several factors; not the least of which is the ability to rapidly scale successful interventions with
fidelity and demonstrated impact. However, the logistics of cost- effective programmatic scale
have proven challenging, with several implementation barriers. Implementation science
defines scalability as the capacity to expand or extend an intervention to account for a growth
factor that aims to fill a gap or address unmet need in a defined population group/geographic
area.
• Data and Information Technology: The enabling environment for data and information
technology is rapidly maturing across countries, creating space, opportunity, and needed
political will to harness the Data Revolution for epidemic control. OUs should consider
innovative ways to use data and information technology to improve efficiency and
sustainability in achieving epidemic control, beyond immediate PEPFAR indicator data
collection needs. As highlighted in the Data Revolution Innovation Toolkit, available on the
PEPFAR SharePoint, OUs are encouraged to explore, adapt, and scale these and other data
driven approaches to move country epidemic control forward.
Nevada profile 2015 stda re'port for cdc#GOMOJO, INC.
Core practices that are moving from a pilot state to implementation at scale: Many of the
barriers facing HIV programs are common across countries. PEPFAR’s ECTs (described below in
Sections 2.3.2 and 2.3.3) identified common issues affecting countries at various levels of
epidemic control and then developed a compendium of evidence-based solutions, approaches
and case-studies that highlight successful means of addressing common barriers. Additional
evidence-based approaches and case-studies will be incorporated into this living compendium
over time. As highlighted in this PEPFAR Solutions Platform, these practices can be rapidly
adapted and scaled to move countries forward.
Key considerations for all PEPFAR programs include:
• Bringing Interventions to Scale with Fidelity: Getting to HIV epidemic control is dependent on
several factors; not the least of which is the ability to rapidly scale successful interventions with
fidelity and demonstrated impact. However, the logistics of cost- effective programmatic scale
have proven challenging, with several implementation barriers. Implementation science
defines scalability as the capacity to expand or extend an intervention to account for a growth
factor that aims to fill a gap or address unmet need in a defined population group/geographic
area.
• Data and Information Technology: The enabling environment for data and information
technology is rapidly maturing across countries, creating space, opportunity, and needed
political will to harness the Data Revolution for epidemic control. OUs should consider
innovative ways to use data and information technology to improve efficiency and
sustainability in achieving epidemic control, beyond immediate PEPFAR indicator data
collection needs. As highlighted in the Data Revolution Innovation Toolkit, available on the
PEPFAR SharePoint, OUs are encouraged to explore, adapt, and scale these and other data
driven approaches to move country epidemic control forward.
Nevada state health division screen shot of site #GOMOJO, INC.
Nevada Prevention and Care Programs
Core practices that are moving from a pilot state to implementation at scale: Many of the
barriers facing HIV programs are common across countries. PEPFAR’s ECTs (described below in
Sections 2.3.2 and 2.3.3) identified common issues affecting countries at various levels of
epidemic control and then developed a compendium of evidence-based solutions, approaches
and case-studies that highlight successful means of addressing common barriers. Additional
evidence-based approaches and case-studies will be incorporated into this living compendium
over time. As highlighted in this PEPFAR Solutions Platform, these practices can be rapidly
adapted and scaled to move countries forward.
Key considerations for all PEPFAR programs include:
• Bringing Interventions to Scale with Fidelity: Getting to HIV epidemic control is dependent on
several factors; not the least of which is the ability to rapidly scale successful interventions with
fidelity and demonstrated impact. However, the logistics of cost- effective programmatic scale
have proven challenging, with several implementation barriers. Implementation science
defines scalability as the capacity to expand or extend an intervention to account for a growth
factor that aims to fill a gap or address unmet need in a defined population group/geographic
area.
• Data and Information Technology: The enabling environment for data and information
technology is rapidly maturing across countries, creating space, opportunity, and needed
political will to harness the Data Revolution for epidemic control. OUs should consider
innovative ways to use data and information technology to improve efficiency and
sustainability in achieving epidemic control, beyond immediate PEPFAR indicator data
collection needs. As highlighted in the Data Revolution Innovation Toolkit, available on the
PEPFAR SharePoint, OUs are encouraged to explore, adapt, and scale these and other data
driven approaches to move country epidemic control forward.
Core practices that are moving from a pilot state to implementation at scale: Many of the
barriers facing HIV programs are common across countries. PEPFAR’s ECTs (described below in
Sections 2.3.2 and 2.3.3) identified common issues affecting countries at various levels of
epidemic control and then developed a compendium of evidence-based solutions, approaches
and case-studies that highlight successful means of addressing common barriers. Additional
evidence-based approaches and case-studies will be incorporated into this living compendium
over time. As highlighted in this PEPFAR Solutions Platform, these practices can be rapidly
adapted and scaled to move countries forward.
Key considerations for all PEPFAR programs include:
• Bringing Interventions to Scale with Fidelity: Getting to HIV epidemic control is dependent on
several factors; not the least of which is the ability to rapidly scale successful interventions with
fidelity and demonstrated impact. However, the logistics of cost- effective programmatic scale
have proven challenging, with several implementation barriers. Implementation science
defines scalability as the capacity to expand or extend an intervention to account for a growth
factor that aims to fill a gap or address unmet need in a defined population group/geographic
area.
• Data and Information Technology: The enabling environment for data and information
technology is rapidly maturing across countries, creating space, opportunity, and needed
political will to harness the Data Revolution for epidemic control. OUs should consider
innovative ways to use data and information technology to improve efficiency and
sustainability in achieving epidemic control, beyond immediate PEPFAR indicator data
collection needs. As highlighted in the Data Revolution Innovation Toolkit, available on the
PEPFAR SharePoint, OUs are encouraged to explore, adapt, and scale these and other data
driven approaches to move country epidemic control forward.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
PEPFAR Prevention Services
1. 25
Prevention Services October 2015
Voluntary Medical Male Circumcision (VMMC)
Indicator code:
VMMC_CIRC
1
Number of males circumcised as part of the voluntary medical male circumcision (VMMC)
for HIV prevention program within the reporting period
Purpose: The total number of males circumcised indicates a change in the supply of and/or demand for VMMC services.
Additionally, disaggregations are required and are used to evaluate whether prioritized services have been successful at
reaching the intended population (by age, HIV status, and circumcision technique), targets have been achieved, and
whether modeling inputs should be adjusted. An additional level of disaggregation below the circumcision technique
level is required for follow-up status, since post-operative clinical assessments are part of good clinical care and low
follow-up rates may indicate a problem in program quality. The follow-up disaggregation of surgical circumcision also
provides denominators for AE
NGI Mapping: P5.1.D continuing, same indicator with modified disaggregations; no impact on trend analysis
PEPFAR Support
Target/Result Type:
Both Direct Service Delivery (DSD) and Technical Assistance-Service Delivery Improvement (TA-
SDI) targets and results should be reported to HQ
Numerator: 1 Number of males provided with voluntary medical male circumcision.
Denominator: N/A
Disaggregation(s): 1 Age: <1, 1-9, 10-14, 15-19, 20-24, 25-29, 30-49, 50+
1
HIV Status:
Number of HIV positive clients (tested HIV positive at VMMC site)
Number of HIV negative clients (tested HIV negative at VMMC site)
Number of clients with unknown HIV status/not tested for HIV on
site/indeterminate6
HIV status/undocumented HIV status
1
Technique:
Number circumcised by device-based technique (Gomco, Mogen Clamp, PrePex, or
other WHO-recognized or prequalified medical device for VMMC)
Number circumcised by surgical technique (forceps guided, dorsal slit, sleeve
resection)
1
Follow-up Status:
Number of surgically circumcised clients who returned at least once for follow-up
care within 14 days of their circumcision surgery
Number of surgically circumcised clients who did NOT return for follow-up care
within 14 days of their circumcision surgery
Data Source: VMMC Register, or client medical records maintained by each program/site/service provider
Data Collection
Frequency:
Data should be collected continuously at the program/site level as part of service delivery and
aggregated in time for PEPFAR reporting cycles. Data should be reviewed regularly for the
purposes of program management, to monitor progress towards achieving targets, and to
identify and correct any data quality issues.
Method of Measurement:
medical records maintained by programs.
Explanation: Males who are provided with circumcision as part of the VMMC for HIV prevention program and in
6
HIV-ind eter m inatestatusisd efined astheHIV statuso fanind ivid ualinwho m ther esultsd id no tlead to d efinitive
d iagno sis,m eaningthatno clear HIV status(either HIV po sitiveo r HIV negative)wasassigned (Deliver ingHIV Test
r esultsand M essagesfo r Re-testingand Co unsellinginAd ults.W HO,2010).
2. 26
accordance with the WHO/UNAIDS/Jhpiego Manual for Male Circumcision Under Local Anesthesia1
, or other WHO
normative guidance (in the case of device-based VMMC), and per national standards by funded programs/sites in the
reporting period meet the definition for the numerator. Males who are provided with circumcision using a medical
device by funded programs/sites in the reporting period also meet the definition for the numerator as long as the device
used is recognized or pre-qualified by WHO.
PEPFAR does not provide funding to perform male circumcision under general anesthesia or sedation, and cases of MC
under general anesthesia/sedation should not be counted in the indicator. Adolescents (10 years of age and older) and
newborns (under 60 days of age) may receive PEPFAR-funded VMMC as long as the procedure is performed using local
anesthesia and in accordance with the WHO/UNAIDS/Jhpiego Manual for Male Circumcision Under Local Anesthesia or
other normative guidance from WHO (in the case of device-based VMMC). For more detailed information on anesthesia
for VMMC, reference the PEPFAR VMMC Technical Considerations.
Programs should focus on compiling data for the numerator from MC Registers or client medical records maintained by
funded programs/sites. For more detailed information on the VMMC minimum package of HIV prevention services, refer
to the PEPFAR VMMC Technical Considerations.
Implications for data collection systems
Implications of the indicator changes on data collection systems are anticipated to be minimal but may require minor
updates to forms, registers, and data collection tools. The required disaggregation for follow-up status necessitates a
system for documenting and reporting of client-level follow-up, which may be challenging. Existing VMMC registers may
already be recording all requisite client-level data, but programs should confirm that these tools accurately reflect the
new disaggregation requirements and
be tracked at the client level if multiple techniques are supported by the same implementing partner.
Explanation of Numerator:
Numerator is the number of males provided with voluntary medical male circumcision. This number is comprised of
those circumcised within the reporting period and disaggregated by age (required), HIV status (required), and
circumcision technique (required). An additional level of disaggregation below the circumcision technique level is
required for follow-up status.
Explanation of Denominator: N/A
Interpretation:
Three randomized controlled clinical trials in sub-Saharan Africa demonstrated a 60% reduction in risk of female-to-male
HIV transmission among men randomized to receive circumcision (compared to uncircumcised controls). This evidence is
supported by long-standing ecologic and observational data. Elective medical male circumcision confers a partially
protective effect against HIV acquisition for HIV-negative men at risk for acquiring HIV from HIV-positive female sexual
partners, and may be particularly beneficial in populations where HIV prevalence is high and male circumcision
prevalence is low. For maximal population impact, uptake of male circumcision should be as high and as rapid as safely
possible and aligned with national policy.
Programs are required to report on the actual number of males circumcised in accordance with the
WHO/UNAIDS/Jhpiego Manual for Male Circumcision Under Local Anesthesia or other WHO normative guidance (in the
case of device-based VMMC) so that the overall uptake and delivery of the PEPFAR-funded VMMC for HIV prevention
services in the country can be monitored, outcomes evaluated, and impact of male circumcision on HIV incidence at a
population level can be modeled. Comparing current and previous values of this indicator may reflect newly
implemented service delivery or changes in volume of supply and/or demand. When the number of male circumcisions is
disaggregated by age and HIV status, it will be possible to adjust inputs used in models to determine impact of male
circumcision programs on HIV incidence. Disaggregation by age may be particularly helpful in determining whether age-
specific communication strategies are working to create demand in particular age groups. Disaggregation by clinical
technique may be helpful to gauge the uptake and acceptability of device-based VMMC. An additional level of
disaggregation below the circumcision technique level is required for follow-up status, since post-operative clinical
3. 27
assessments are part of good clinical care and low follow-up rates may indicate a problem in program quality. The follow-
up disaggregation of surgical circumcision also provides denominators for AE rates using numerators from indicator
-PEPFAR funded providers also performing MCs within the reporting period are not included in this
indicator, and any broader evaluations of population-level uptake will need to be interpreted accordingly.
Services are provided as part of a minimum package of MC for HIV prevention services per national standards and in
accordance with the WHO/UNAIDS/Jhpiego Manual for Male Circumcision Under Local Anesthesia or other WHO
normative guidance (in the case of device-based VMMC).
PEPFAR Support:
DSD: Individuals will be counted as receiving direct service delivery support from PEPFAR when BOTH of the below
conditions are met: Provision of key staff or commodities AND frequent, at least quarterly, support to improve the
quality of services.
TA-SDI: Individuals will be counted as supported through TA-SDI when the point of service delivery receives support
from PEPFAR that meets the second criterion only: Frequent, at least quarterly support to improve the quality of
services.
1. PEPFAR is directly interacting with the patient or beneficiary in response to their health (physical, psychological,
etc.) care needs by providing key staff and/or essential commodities for routine service delivery. For males
receiving VMMC, this can include procurement of critical commodities such as medical instruments, supplies, or
medicines needed for the VMMC procedure, or funding for salaries for HCW who deliver VMMC services. Staff
who are responsible for the completeness and quality of routine patient records (paper or electronic) can be
counted here; however, staff who exclusively fulfill MOH and donor reporting requirements cannot be counted.
AND/OR
2. PEPFAR provides an established presence at and/or routinized, frequent (at least quarterly) support for those
services at the point of service delivery. For VMMC services, this ongoing support for service delivery
improvement can include: training of VMMC service providers; clinical mentoring and supportive supervision of
HCW at VMMC sites; infrastructure/facility renovation; support of VMMC service-related data collection,
reporting, data quality assessments (DQA); CQI/EQA of VMMC services at point of service delivery; or
commodities consumption forecasting and supply chain management support.
Additional References:
A Guide to Indicators for Male Circumcision Programmes in the Formal Health Care System. WHO and UNAIDS.
December 2009. (http://whqlibdoc.who.int/publications/2009/9789241598262_eng.pdf)
Manual for Male Circumcision Under Local Anesthesia. WHO/UNAIDS/Jhpiego. December 2009.
(http://www.who.int/hiv/pub/malecircumcision/who_mc_local_anaesthesia.pdf)